Login
Register
Back to News
Lisata Therapeutics shares are trading higher after the company entered into a definitive agreement to be acquired by Kuva Labs.
Benzinga Newsdesk
www.benzinga.com
Positive 95.0%
Neg 0%
Neu 0%
Pos 95%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment